Premium
Gain of chromosome 21 or amplification of chromosome arm 21q is one mechanism for increased ERG expression in acute myeloid leukemia
Author(s) -
Weber Simone,
Haferlach Claudia,
Jeromin Sabine,
Nadarajah Niroshan,
Dicker Frank,
Noël Louisa,
Zenger Melanie,
Alpermann Tamara,
Kern Wolfgang,
Haferlach Torsten,
Schnittger Susanne
Publication year - 2016
Publication title -
genes, chromosomes and cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.754
H-Index - 119
eISSN - 1098-2264
pISSN - 1045-2257
DOI - 10.1002/gcc.22321
Subject(s) - biology , erg , fluorescence in situ hybridization , myeloid leukemia , microbiology and biotechnology , chromosome 21 , chromosomal translocation , chromosome 18 , genetics , chromosome , gene , cancer research , retina , neuroscience
In acute myeloid leukemia (AML), acquired genomic gains and losses are common and lead to altered expression of genes located within or nearby the affected regions. Increased expression of the ETS‐related transcription factor gene ERG has been described in myeloid malignancies with chromosomal rearrangements involving chromosome band 21q22, but also in cytogenetically normal AML, where it is associated with adverse prognosis. In this study, fluorescence in situ hybridization on interphase nuclei disclosed an amplification of the ERG gene (more than six copies) in 33 AML patients with structural rearrangements of 21q22. Array comparative genomic hybridization of these cases disclosed a minimal amplified region at the position 39.6–40.0 Mbp from pter that harbors ERG as the only gene. Analysis by quantitative real‐time reverse transcription polymerase chain reaction revealed significantly higher ERG mRNA expression in these patients and in a group of 95 AML patients with complete or partial gain of chromosome 21 (three to six copies) compared with 351 AML patients without gain of chromosome 21. Quantification of ERG DNA copy numbers revealed a strong correlation with ERG mRNA expression. Furthermore, in patients with gain of chromosome 21, higher ERG expression was found to be associated with RUNX1 mutations. Our results suggest that acquired gain of chromosome 21 or amplification of chromosome arm 21q is one mechanism contributing to increased ERG expression in AML. © 2015 Wiley Periodicals, Inc.